OvaCure - curing ovarian cancer together OvaCure is a scientific innovation incubator, accelerating curative cancer treatments in the fight against ovarian cancer. Non-profit. OvaCure's focus is on accelerating new treatments that have curative potential, and delivering treatment faster to patients. Each of OvaCure's projects are innovative and directly related to treatment of patients. Our method is unique, and we have congregated some of the world's Key Opinion Leaders. Our collective efforts can lead to significantly improved treatment possibilities for women with ovarian cancer. Why focus on ovarian cancer? For the majority of women with ovarian cancer today, there is no curative treatment. Ovarian cancer is the fourth leading cause of cancer death in women in the developed world. Currently there are 239,000 new cases of ovarian cancer diagnosed annually and 140,000 women die each year from the disease worldwide. Of all women with ovarian cancer, 70% are diagnosed in an advanced stage (stages III or IV), of which only 25% survive for more than 5 years. Unique collaboration with leading Key Opinion Leaders The OvaCure Scientific and Clinical Advisory Board has been established, which includes some of the most recognised internationally experts in oncology, immunotherapy and gynaecology. During the annual OvaCure Innovation Summit, the Advisory Scientific and Clinical Board work with the leading experts to develop innovative new projects with curative potential. The selected projects are then offered financial support. OvaCure is a catalyst for innovative international partnerships and projects OvaCure fosters strategic partnerships between leading international experts in medicine, research, government, NGOs and various foundations. OvaCure acts as a think tank in close cooperation with these influential figures to initiate and co-create innovative research projects. Learn more at www.ovacure.org